{"url_path":"/sec/aura/8-k/2026-08-11/item-9-01","section_key":"item-9-01","section_title":"Item 9.01 Financial Statements and Exhibits.","topic":"sec","document":{"doc_type":"8-K","doc_date":"2026-08-11","source_url":"https://www.sec.gov/Archives/edgar/data/1501796/0001193125-26-343408-index.html","accession_number":"0001193125-26-343408","cik":"0001501796","ticker":"AURA","issuer_name":"Aura Biosciences, Inc.","edgar_url":"https://www.sec.gov/Archives/edgar/data/1501796/0001193125-26-343408-index.html","primary_entity_key":"0001501796","primary_entity_name":"Aura Biosciences, Inc."},"word_count":88,"has_tables":true,"body_markdown":"Item 9.01 Financial Statements and Exhibits.\n\n(d) Exhibits.\n\nExhibit No.\n\nDescription\n\n99.1\n\n[Press Release Dated August 11, 2026.](aura-ex99_1.htm)\n\n99.2\n\n[Corporate Presentation of the Company.](aura-ex99_2.htm)\n\n104\n\nCover Page Interactive Data File (embedded within the Inline XBRL document).\n\n \n\nSIGNATURES\n\nPursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.\n\n \n\n \n\n \n\n \n\nAura Biosciences, Inc.\n\n \n\n \n\n \n\n \n\nDate:\n\nAugust 11, 2026\n\nBy:\n\n/s/ Natalie Holles\n\n \n\n \n\n \n\nNatalie Holles\n\nChief Executive Officer and President\n\n(Principal Executive Officer)"}